Cargando…

Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signaling

Vasohibin‐2 (VASH2) is a homolog of VASH1, an endothelium‐derived angiogenesis inhibitor. Vasohibin‐2 is mainly expressed in cancer cells, and has been implicated in the progression of cancer by inducing angiogenesis and tumor growth. Although VASH2 has been recently reported to be involved in epith...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norita, Rie, Suzuki, Yasuhiro, Furutani, Yutaka, Takahashi, Kazuki, Yoshimatsu, Yasuhiro, Podyma‐Inoue, Katarzyna A., Watabe, Tetsuro, Sato, Yasufumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378260/ https://www.ncbi.nlm.nih.gov/pubmed/28064471 http://dx.doi.org/10.1111/cas.13157

Ejemplares similares

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

Age‐associated downregulation of vasohibin‐1 in vascular endothelial cells
por: Takeda, Eichi, et al.
Publicado: (2016)

The Vasohibin Family
por: Sato, Yasufumi
Publicado: (2010)

Targeting human vasohibin‐2 by a neutralizing monoclonal antibody for anti‐cancer treatment
por: Koyanagi, Takahiro, et al.
Publicado: (2017)

Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
por: Ito, Soichi, et al.
Publicado: (2013)

TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2020)

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells
por: KOYANAGI, TAKAHIRO, et al.
Publicado: (2013)

Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation
por: Suenaga, Kaori, et al.
Publicado: (2014)

Requisite role of vasohibin‐2 in spontaneous gastric cancer formation and accumulation of cancer‐associated fibroblasts
por: Suzuki, Yasuhiro, et al.
Publicado: (2017)

Transforming growth factor-β-induced secretion of extracellular vesicles from oral cancer cells evokes endothelial barrier instability via endothelial-mesenchymal transition
por: Kobayashi, Miho, et al.
Publicado: (2022)

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis
por: Kitahara, Shuji, et al.
Publicado: (2014)

TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of Activin signals
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2020)

Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2
por: Horie, Sachiko, et al.
Publicado: (2023)

The crystal structure of the tetrameric human vasohibin-1–SVBP complex reveals a variable arm region within the structural core
por: Ikeda, Akihito, et al.
Publicado: (2020)

Vasohibin‐1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
por: Takahashi, Yoshifumi, et al.
Publicado: (2016)

Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity
por: Sato, Yasufumi
Publicado: (2018)

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
por: Miyashita, Hiroki, et al.
Publicado: (2011)

Emerging roles of inflammation-mediated endothelial–mesenchymal transition in health and disease
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2022)

Roles of TGF-β Signals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2011)

Knockout of Vasohibin-1 Gene in Mice Results in Healthy Longevity with Reduced Expression of Insulin Receptor, Insulin Receptor Substrate 1, and Insulin Receptor Substrate 2 in Their White Adipose Tissue
por: Takeda, Eichi, et al.
Publicado: (2017)

The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
por: TAKAHASHI, YOSHIFUMI, et al.
Publicado: (2015)

High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
por: Watanabe, Tatsuaki, et al.
Publicado: (2018)

Progression of melanoma is suppressed by targeting all transforming growth factor-β isoforms with an Fc chimeric receptor
por: Kodama, Shingo, et al.
Publicado: (2021)

Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1
por: Miyashita, Hiroki, et al.
Publicado: (2012)

Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
por: Okuyama, Michihiro, et al.
Publicado: (2019)

Activation of β2‐adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells
por: Sakakitani, Shintaro, et al.
Publicado: (2020)

Dual targeting of vascular endothelial growth factor and bone morphogenetic protein‐9/10 impairs tumor growth through inhibition of angiogenesis
por: Akatsu, Yuichi, et al.
Publicado: (2017)

Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma
por: Okamoto, Hayato, et al.
Publicado: (2019)

Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
por: Miyake, Hiromasa, et al.
Publicado: (2020)

Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis
por: Miyazaki, Hideki, et al.
Publicado: (2014)

Vasohibin‐1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction
por: Watatani, Hiroyuki, et al.
Publicado: (2014)

Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer
por: Koyanagi, Takahiro, et al.
Publicado: (2021)

Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1
por: Zhou, Shi-you, et al.
Publicado: (2010)

Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization
por: Onami, Hideyuki, et al.
Publicado: (2013)

Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1
por: Akatsu, Yuichi, et al.
Publicado: (2019)

Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer
por: Kobayashi, Hiroaki, et al.
Publicado: (2017)

Vasohibin-1 suppresses colon cancer
por: Liu, Shuai, et al.
Publicado: (2015)

Structural basis of tubulin detyrosination by vasohibins
por: Li, Faxiang, et al.
Publicado: (2019)

Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model
por: Masuda, Kana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rgsr7r6l0s931ot4q33apl99jt